Zacks Investment Research
30 Jun 2026, 09:25 UTC · 12w ago
Verdict
Headline takes no side. We score FUL +0.80 across five claims — strongly bullish.
+0.80strongly bullish
More positive than 85% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
H.B. Fuller's second-quarter fiscal 2026 adjusted EPS of $1.41 and revenues of $950.3 million both beat Zacks Consensus Estimates.
More positive than 77% of claims this week
The company is pursuing a strategic shift into medical adhesives, highlighted by a proposed deal for Advanced Medical Solutions.
So whatExpansion into high-margin healthcare sectors represents a long-term growth catalyst and diversification of the portfolio.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 63% of claims this week
Adjusted gross margins expanded by 200 basis points to 34.2%, driven by pricing execution and restructuring savings.
So whatMargin expansion indicates pricing power and operational efficiency, which improves valuation multiples.
More positive than 63% of claims this week
Net debt to adjusted EBITDA improved to 3.1x from 3.4x year-over-year.
More positive than 50% of claims this week
Engineering Adhesives organic growth was offset by a solar business exit, though aerospace grew by over 30% and electronics saw double-digit gains.
More positive than 41% of claims this week
Which stocks this story touches
More positive than 85% of ticker scores this week
The company beat earnings and revenue estimates, showed adjusted EPS and EBITDA growth, and reported record operating cash flow.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2h ago
−15.8%
Price is moving against the score
$49.82 vs $59.14 close before publication (Jun 29) · not market-adjusted
FUL chart →
